Riskpilot← Back to searchSign inGet full accessSpatial Transcriptomics Holding AB
ABDissolvedOrg 5569030611Economic activity was not specified by tax authority · NACE 0000Est. 20120 employees
Revenue 2022
SEK 0
EBITDA margin
—
-129% vs 2021
Equity ratio
88.1%
Financial strength
Net profit 2022
SEK -80K
-122% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -80K | -129% |
| Net profit | SEK -80K | -122% |
| Total assets | SEK 24,7M | +0% |
| Equity | SEK 21,7M | +0% |
| Employees | 0 | — |
Legal name
Spatial Transcriptomics Holding AB
Org number
5569030611
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
6 september 2012
Share capital
SEK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva verksamhet relaterad till biomedicin, förvaltning av lös och fast egendom och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −292 | −205 | −860 | −7 852 | −1 719 | −52 | −35 | −80 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −292 | −205 | −860 | −7 852 | −1 719 | −52 | −35 | −80 |
| Net financials | — | −728 | −3 957 | −2 452 | −3 | −1 | −1 | — |
| Profit before tax | −292 | −934 | −4 817 | −10 305 | 6 758 | 2 462 | −36 | −80 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −292 | −934 | −4 817 | −10 305 | 6 758 | 2 462 | −36 | −80 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 758 | 1 964 | 21 593 | 17 153 | 22 956 | 24 862 | 24 731 | 24 650 |
| Equity | 258 | 1 424 | 21 347 | 13 156 | 19 375 | 21 837 | 21 801 | 21 721 |
| Long-term debt | 0 | 500 | 0 | 0 | 2 899 | 2 899 | 2 899 | 2 899 |
| Short-term debt | 500 | 40 | 245 | 3 997 | 682 | 126 | 31 | 30 |
| Total debt | 500 | 540 | 245 | 3 997 | 3 581 | 3 025 | 2 930 | 2 929 |
EBITDA margin
-8000000.0%
This company
15.8%
Market median
-50633011% vs market
20152022
Equity ratio
88.1%
This company
38.2%
Market median
+131% vs market
20152022
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20152022
Net profit margin
-8000000.0%
This company
8.1%
Market median
-98765532% vs market
20152022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152022
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20152022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PM Chief Auditor | Chief Auditor | 2021 | — | — |
IZ Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
10X Genomics, Inc | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
10X Genomics, Inc
Spatial Transcriptomics Holding AB Board members of Spatial Transcriptomics Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Morgan Sandström | Chief Auditor | 0 companies |
| Iuliia Zhuravel | Chief Auditor | 0 companies |
| Jonas Kristoffer Frisén | Board of Directors | 0 companies |
| Ehsan Banisaid | Board of Directors | 0 companies |
| Michael John Terry Stubbington | Board of Directors | 0 companies |
| Eric Stewart Whitaker | Chairman | 0 companies |
| Elmar Ahmadov | Board of Directors | 0 companies |